Citation Impact
Citing Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
2005
Poverty Impedes Cognitive Function
2013 StandoutScience
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.
1991
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
2005 Science
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis
1997
Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological and clinical study.
1987
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis
1993
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
2010
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
2008
Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis
1995
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Smoking and Inflammatory Bowel Disease: A Meta-analysis
2006
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Review article: the role of butyrate on colonic function
2007 Standout
Review article: infliximab therapy for inflammatory bowel disease – seven years on
2006
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
2009
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
2014
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease
2006
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis
1996
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
2008
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
2004
Long-term treatment of rectovaginal fistulas in Crohn’s disease: Response to infliximab in the ACCENT II Study
2004
Transdermal Nicotine for Active Ulcerative Colitis
1994
The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease
1999
Cryopyrin activates the inflammasome in response to toxins and ATP
2006 StandoutNature
The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives
1989
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
Guidelines for the management of inflammatory bowel disease in adults
2011
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
2005
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
2010
Colonoscopic surveillance in long-standing total ulcerative colitis—A 15-year follow-up study
1990
Clinical Characteristics of Inflammatory Bowel Disease in Turkey
2008
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis
2010
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
2014
Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum
2008
Ulcerative colitis—what is the risk of developing colorectal cancer?
1991
Male Issues of the Ileal Pouch
2014
Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
2004
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
2016
When Checkpoints Fail
1997 StandoutNobel
Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients
2016
Anti-TNF-alpha therapy in ankylosing spondylitis
2006
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Dietary Factors and Risk of Colon Cancer
1994
The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis
2008
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
2009 StandoutNature
Lessons from Hereditary Colorectal Cancer
1996 Standout
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
2003
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
2013
Optimizing the safety of biologic therapy for IBD
2010
G Protein-Coupled Receptor 43 Moderates Gut Inflammation Through Cytokine Regulation from Mononuclear Cells
2013
Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
2006
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
2011
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
2013
Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study
1997
Inflammatory Bowel Disease and Smoking
2004
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
2005
Future biologic targets for IBD: potentials and pitfalls
2010
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Pouchitis: What Every Gastroenterologist Needs to Know
2013
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
2008
Inflammatory Bowel Disease
1991 Standout
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Role of β7 Integrin and the Chemokine/Chemokine Receptor Pair CCL25/CCR9 in Modeled TNF-Dependent Crohn's Disease
2008
European consensus on the histopathology of inflammatory bowel disease
2013
Ulcerative colitis
2012 Standout
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
1994
Ileal Pouch Anal Anastomosis
2013
Adalimumab for the treatment of fistulas in patients with Crohn’s disease
2009
Systematic review: infliximab therapy in ulcerative colitis
2006
Crohn's disease
2016 Standout
Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease
1991
Inflammatory Bowel Disease
2002 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions
1993
Immunity, Inflammation, and Cancer
2010 Standout
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
2012
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
2005
Deoxyribonucleoside triphosphate levels: A critical factor in the maintenance of genetic stability
1994
A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
2012
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Acute Gastroenteritis Is Followed by an Increased Risk of Inflammatory Bowel Disease
2006
Certolizumab Pegol for the Treatment of Crohn's Disease
2007
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
2006
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease
2007
Small Bowel Adenocarcinoma in Patients with Crohnʼs Disease Compared with Small Bowel Adenocarcinoma De Novo
2005
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
New Concepts in Intestinal Imaging for Inflammatory Bowel Diseases
2011
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Colonic Health: Fermentation and Short Chain Fatty Acids
2006 Standout
TGFβ in Cancer
2008 Standout
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative Colitis
2007
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
2006
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk
2004
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
2004
Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
2010
Optimizing anti-TNF treatments in inflammatory bowel disease
2013
Targeted Deletion of Metalloproteinase 9 Attenuates Experimental Colitis in Mice: Central Role of Epithelial-Derived MMP
2005
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia
2015
Biomarkers of Inflammation in Inflammatory Bowel Disease
2015
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2012
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
2009
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
A Population-Based Case Control Study of Potential Risk Factors for IBD
2006
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial
2002
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
2000
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
2011
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
2013
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
Cancer in patients with ulcerative colitis
1995
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis
2002
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Tumour necrosis factor and cancer
2009
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
2008
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
2004
Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial
2003
Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease
2005
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
2010
Cancer-related inflammation
2008 StandoutNature
The inflammatory reflex
2002 StandoutNature
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease
2006
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies
2005
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Guidelines for the management of inflammatory bowel disease in adults
2004
Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
2010
Endoscopic evaluation of patients with inflammatory bowel disease
2008
An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's Disease
2004
Expression and membrane localization of MCT isoforms along the length of the human intestine
2005
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Predominant T helper type 2‐inflammatory responses promote murine colon cancers
2005
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
2006
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis.
1993
Transformation of the Nitrogen Cycle: Recent Trends, Questions, and Potential Solutions
2008 StandoutScience
Folate Deficiency and Cervical Dysplasia
1992
Workgroup Report: Drinking-Water Nitrate and Health—Recent Findings and Research Needs
2005 Standout
Nicotine treatment for ulcerative colitis
1999
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease
2016
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
[Colorectal cancer in ulcerative colitis].
2014
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
2013
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Colorectal cancer prevention in ulcerative colitis: a case‐control study
2000
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis
2003
Inflammatory Bowel Disease
2010 Standout
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis
1997
Failure of colonoscopic surveillance in ulcerative colitis.
1993
Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
2018
Review article: optimal preparation for surgery in Crohn's disease
2014
Meat consumption, health, and the environment
2018 StandoutScience
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.
2000
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis
2008
Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase
1997 StandoutNobel
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
2008
The Dual Role of Neutrophils in Inflammatory Bowel Diseases
2016
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
2006
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage
1997
DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair
1997 StandoutNobel
Familial Occurrence of Inflammatory Bowel Disease
1991
Works of Bret A. Lashner being referenced
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.
1997
Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis
2004
Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease
2006
A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis
2001
Safety of Infliximab: Primum non nocere
2004
Clinical Approach to Diseases of Ileal Pouch-Anal Anastomosis
2005
Hazard rates for dysplasia and cancer in ulcerative colitis
1989
Application of Wireless Capsule Endoscopy for the Evaluation of Iron Deficiency Anemia in Patients With Ileal Pouches
2008
Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis
2007
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
2000
A Proposed Classification of Ileal Pouch Disorders and Associated Complications After Restorative Proctocolectomy
2008
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
2010
Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients
2008
Dysplasia and cancer complicating strictures in ulcerative colitis
1990
Cigarette Smoking and Ulcerative Colitis: A Case-Control Study
1994
Predictors of response to infliximab in patients with Crohn's disease
2002
Testing nicotine gum for ulcerative colitis patients
1990
Differentiating risk factors for acute and chronic pouchitis
2005
Preoperative total parenteral nutrition for bowel resection in Crohn's disease
1989
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
2007
Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis
2002
Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis
1993
Intestinal Adenocarcinoma in Crohn's Disease
1999
Association Between Immune-Associated Disorders and Adverse Outcomes of Ileal Pouch-Anal Anastomosis
2009
Endoscopic Balloon Dilation of Ileal Pouch Strictures
2004
Colorectal Cancer Surveillance for Patients with Inflammatory Bowel Disease
2002
Adenocarcinoma complicating Crohn's disease
1993
Comprehensive Evaluation of Inflammatory and Noninflammatory Sequelae of Ileal Pouch-Anal Anastomoses
2005
Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis
2004
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis
2005
Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
2008
Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch
2006
Lack of association between oral contraceptive use and Crohn's disease: A community-based matched case-control study
1989
The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis
1999
Risk factors for small bowel cancer in Crohn's disease
1992
Cost-effectiveness of Quantitative Fecal Lactoferrin Assay for Diagnosis of Symptomatic Patients With Ileal Pouch-anal Anastomosis
2008
Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice
2005
Family history of Crohnʼs disease is associated with an increased risk for Crohnʼs disease of the pouch
2008
Afferent limb ulcers predict Crohn’s disease in patients with ileal pouch-anal anastomosis☆
2004
Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis
2001
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
Effect of Withdrawal of Nonsteroidal Anti-Inflammatory Drug Use on Ileal Pouch Disorders
2007
Indicators of Clinical Response to Treatment with Six-Mercaptopurine or Azathioprine in Patients with Inflammatory Bowel Disease
2004
Modified Pouchitis Disease Activity Index
2003
Evaluation of The Usefulness of Testing for P53 Mutations in Colorectal Cancer Surveillance for Ulcerative Colitis
1999
Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease
2004
Risk Factors for Diseases of Ileal Pouch–Anal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis
2006
Once daily dosing of delayed-release oral mesalamine for maintenance of remission of Ulcerative Colitis (the QDIEM Trial): 6 and 12 month results
2009
Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.
1990
Lack of association between oral contraceptive use and ulcerative colitis
1990
Optimal Timing of Colonoscopy to Screen for Cancer in Ulcerative Colitis
1988
Collagenous pouchitis
2006
Cancer Biology in Ulcerative Colitis and Potential Use in Endoscopic Surveillance
1997
Cigarette smoking in Crohn's disease.
1989
Smoking and inflammatory bowel disease in families.
1988
Clinical epidemiology of inflammatory bowel disease
1994
Ganglioneuromatosis of the colon and extensive glygogenic acanthosis in Cowden's disease
1986
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis
1989
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
1993
Infliximab is more efficacious for treatment of enterocutaneous fistulas compared to rectovaginal fistulas in patients with Crohn's disease
2001
Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.
1995
Prevalence and incidence of inflammatory bowel disease in family members
1986
Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
1993
Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate.
1992